Page last updated: 2024-10-26

donepezil and Astrocytoma, Grade IV

donepezil has been researched along with Astrocytoma, Grade IV in 1 studies

Donepezil: An indan and piperidine derivative that acts as a selective and reversible inhibitor of ACETYLCHOLINESTERASE. Donepezil is highly selective for the central nervous system and is used in the management of mild to moderate DEMENTIA in ALZHEIMER DISEASE.
donepezil : A racemate comprising equimolar amounts of (R)- and (S)-donepezil. A centrally acting reversible acetylcholinesterase inhibitor, its main therapeutic use is in the treatment of Alzheimer's disease where it is used to increase cortical acetylcholine.
2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxyindan-1-one : A member of the class of indanones that is 5,6-dimethoxyindan-1-one which is substituted at position 2 by an (N-benzylpiperidin-4-yl)methyl group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Nepali, K1
Wu, AC1
Lo, WL1
Chopra, B1
Lai, MJ1
Chuang, JY1
Liou, JP1

Other Studies

1 other study available for donepezil and Astrocytoma, Grade IV

ArticleYear
Rationally designed donepezil-based hydroxamates modulate Sig-1R and HDAC isoforms to exert anti-glioblastoma effects.
    European journal of medicinal chemistry, 2023, Feb-15, Volume: 248

    Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Donepezil; Glioblastoma; Histone Dea

2023